Main

Drug Disposition & Pharmacokinetics

Switching from Other Agents to Extended-Release Carbamazepine in Acute Mania
By Rif S. El-Mallakh, MD, Terence A. Ketter, MD, Richard H. Weisler, MD, Robert Hirschfeld, MD, Andrew J. Cutler, MD, Thomas Gazda, MD, Paul Keck, Jr, MD, Alan C. Swann, MD, and Amir H. Kalali, MD

The Effect of Food on the Absorption of Oral Ziprasidone
By Jeffrey J. Miceli, PhD, Paul Glue, MD, PhD, Jeffrey Alderman, PhD, and Keith Wilner, PhD

Long-Acting Injectable Risperidone in the Treatment of Schizophrenia in Special Patient Populations
By Eduard Parellada, MD, MSc, PhD

Drug–Drug Interactions Associated with Second-Generation Antipsychotics: Considerations for Clinicians and Patients
Robert R. Conley, MD and Deanna L. Kelly, PharmD, BCPP

Efficacy of Olanzapine and Risperidone in Schizophrenia:A Randomized Double-Blind Crossover Design
By Jose M. Canive, MD, Gregory A Miller, PhD, Jessica G. Irwin, BS, Sandra N. Moses, PhD, Robert J. Thoma, PhD, J. Christopher Edgar, PhD,
Andrea Sherwood, PhD, Fernando Torres, MD, Marianna LaNoue, PhD,  Stephen Lewis, MD, Faith M. Hanlon, PhD, Michael P. Weisend, PhD,
Valerie Mead, MD, and Vicente B. Tuason, MD

 

Posted on Tuesday, March 25, 2008 at 02:31PM by Registered CommenterContacts in | CommentsPost a Comment

Reader Comments

There are no comments for this journal entry. To create a new comment, use the form below.

PostPost a New Comment

Enter your information below to add a new comment.

My response is on my own website »
Author Email (optional):
Author URL (optional):
Post:
 
Some HTML allowed: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <code> <em> <i> <strike> <strong>